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Abstract 
Objective: No published data are available that currently evaluate Chinese adult women’s 
cervical cancer prevention practices through screening and vaccination using population-based 
samples. This study describes patterns and correlates of these behaviours among Hong Kong 
Chinese women aged 30-59 years.  
Methods: From February to November 2014 a random sample of 1,482 Hong Kong Chinese 
women having at least one 12-17 year-old daughter, who had heard of HPV vaccine before but 
had not sought HPV vaccination for daughter(s) completed structured telephone interviews. 
Multiple logistic regression analyses were conducted to examine factors associated with 
participants’ cervical screening attendance, HPV vaccination uptake and intention to uptake. 
Results: Overall, 80.8% of the participants reported attending asymptomatic cervical screening 
and 73% had regular screening. Family income and attitudes to cervical smear testing were 
associated with asymptomatic cervical screening attendance. Only 3.0% (45/1482) of all 
participants had received HPV vaccination. Among those who had not received HPV vaccination, 
12.3% (183/1437) indicated positive intentions. Age below 50, household income and 
encouragement from family/friends were significantly associated with women’s intended and 
actual uptake of HPV vaccination. Trusting formal and informal HPV vaccination information 
was positively associated with vaccination intention, while lack of concrete recommendation 
from doctors was negatively associated with vaccination uptake.  
Conclusions: Information trust was associated with vaccination intention but not actual uptake 
whereas encouragement from family/friends facilitates women’s HPV vaccination. Continued 
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efforts are needed to ensure Chinese women adopting cervical cancer preventive behaviours, and 
must consider different specific needs of population subgroups.  
Key words: Cervical cancer; cancer prevention; screening; Human papillomavirus; vaccine 
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Introduction 
Cervical cancer is the fourth most common cancer in women globally causing an estimated 
266,000 death worldwide in 2012 [1]. Cervical screening and probably HPV vaccination provide 
effective prevention reducing the disease burden. The Hong Kong Cancer Registry 2012 
indicates a local age-standardised incidence rate (ASR) for cervical cancer of 8.2 per 100,000 
standard population [2], indicating a cervical cancer prevalence intermediate to other developed 
societies such as Australia/New Zealand (around 5.5 per 100,000) and Russia (around 15.3 per 
100,000) [1]. In March 2004 an organized Cervical Screening Program (CSP) was launched by 
the Maternal & Child Health Centres (MCHCs) of the Hong Kong Department of Health (DH) 
for 25-64 year-old women with prior sexual experience [3]. However, the program does not 
proactively recruit eligible but never-screened women. Such women have to proactively seek 
cervical smear services from family doctors, general practitioners or gynecologists. The charge 
for a cervical smear varies among different service providers, ranging from about HK$100 
(~US$13) to HK$1,000 (~US$130), depending on whether it is a standalone test or part of a 
health check package, type of smear performed and who performs the test. As of 2012 nearly 
one-third of eligible women in Hong Kong had never had a cervical smear [3]. Previous local 
studies found that the most commonly cited reasons for failure to utilize cervical screening were 
ignorance regarding service access, inconvenience, cost, and embarrassment [4-6]. 
 
Two types of Human Papillomavirus (HPV) vaccines (Gardasil® and Cervarix®) were 
introduced in Hong Kong in 2006 and 2007, respectively. Cervarix® is approved for use in 
females from 9 years of age onwards. Gardasil® is approved for use in females aged 9 to 45 
years (and also approved for use in males aged 9 to 26 years for prevention of genital warts 
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caused by HPV types 6 and 11) [7]. Although the main population for prophylactic HPV 
vaccination is adolescent girls and young women before sexual debut, adult women who often 
show strong interest in the vaccine [8] may also benefit from HPV vaccination [9]. A recent 
multinational randomised controlled trial study reported that vaccine efficacy against HPV 
16/18-related 6-month persistent infection or cervical intraepithelial neoplasia grade 1 or higher 
(CIN1+) was significant in all age groups of women aged 26 and above with a combined efficacy 
of 81.1% (97.7% confidence interval 52.1–94.0) [10]. In Hong Kong, HPV vaccination is widely 
promoted almost exclusively through manufacturer-funded advertising and remains an individual 
choice. Intending recipients must seek HPV vaccination services from private providers and pay 
the full cost, currently around HK$3,000 (~US$390) for the 3-dose injection. Previous studies of 
Chinese women found misconceptions and knowledge deficits to be common regarding cervical 
cancer, HPV infection and HPV vaccination [11-17]. However, most of the studies involving 
Hong Kong Chinese women were conducted shortly after HPV vaccines were first marketed, and 
focused on women’s intention to vaccinate their daughters against HPV rather than their own 
acceptability to receive the vaccine. The only local quantitative study assessing Chinese adult 
women’s own intention to receive HPV vaccination was conducted in 2007 found that despite 
misconceptions and inadequate knowledge about HPV and HPV vaccination, about 88% of the 
women indicated they would like to be vaccinated [16]. Women aged below 50 and who 
perceived a disruptive impact of HPV infection on current intimate relationship were more 
willing to be vaccinated. Responses of partner/family towards vaccination played an important 
role influencing Chinese women’s intention to receive HPV vaccination [16]. However, so far no 
published data are currently available about the actual uptake of HPV vaccination among adult 
Chinese women after 8 years of HPV vaccine-related marketing. A more updated study is 
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warranted given women’s acceptability may have changed significantly in the interim since 
information about cervical cancer risk and prevention has been more widely promulgated. 
Many overseas studies reported that recommendations from healthcare providers have positive 
association with young and adult women’s decision-making for HPV vaccination [18-20]. 
Empirical studies also suggest that people more trusting of formal information, that from media, 
government or health professionals, are more likely to adopt active health-protective behaviours 
[21, 22]. Lack of concrete vaccination advice from healthcare providers is commonly reported by 
local qualitative studies, with some women receiving conflicting views about HPV vaccination 
from different health professionals [23, 24]. Population-based studies are essential to assess the 
effect of information trust from formal and informal (family, friends, and colleagues) sources on 
adult women’s HPV vaccination decision-making. 
In this study we aimed to describe the patterns of cervical cancer prevention practices through 
screening and HPV vaccination among Hong Kong adult women and to identify socio-
demographic correlates of their cervical cancer prevention behaviours. With particular interest in 
the effects of information trust, we hypothesized that (1) Trust in formal information about HPV 
vaccination and receiving positive vaccination advice from doctors are positively associated with 
women’s intended and actual vaccination uptake, and (2) Trust in informal information about 
HPV vaccination and being encouraged by family/friends is positively associated with women’s 
intended and actual vaccination uptake.  
Methods  
Subjects  
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As part of an ongoing longitudinal study investigating HPV vaccination decision-making among 
Hong Kong Chinese parents who (1) had at least one daughter aged 12-17 years, (2) had heard of 
HPV vaccine (3) but had not yet vaccinated daughters against HPV, the baseline data collected 
from mothers were analyzed in the present study. 
Procedures 
Because 98% of Hong Kong households have landline phones with free local calls, random-digit 
dialling telephone interviews were conducted for data collection by a Web-based Computer 
Assisted Telephone Interview (Web-CATI) system. To avoid oversampling of non-workers, 
most interviews were conducted between 18:30 and 22:30 on weekdays, and between 14:00 and 
22:30 at weekends, though some were conducted between 14:00 and 18:00 at weekdays. To 
minimize sample bias, households with unanswered phone numbers were redialled at least 6 
more times during different periods (2 weekdays, 3 weeknights, and 2 weekends) before being 
dropped and replaced by another number. Each contacted household was screened according to 
the inclusion and exclusion criteria. If the target subject refused to participate, the household was 
classified as a refusal and another telephone number used with the process being repeated until 
the target sample size was reached. Verbal consent was obtained from each eligible participant 
prior to interview. No incentive was provided to participants. Ethical approval was obtained from 
the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong 
West Cluster. 
Measures 
In addition to demographic information, participant women were asked about their attitudes 
towards and attendance of cervical screening, HPV vaccination uptake and intention to uptake. 
5 
 
Attitude to cervical smear test was measured by 4 items responding to a 5-point agreement scales 
ranging from 1 “Strongly disagree” to 5 “Strongly agree” drawing from Cervical Smear Belief 
Inventory, previously validated in a Chinese population [25]. Two items measured the pros of 
cervical smear: “(1) A cervical smear can find the problem before it develops into cancer; (2) 
The earlier a cervical cancer is detected, the higher chance of a cure.” Another two measured 
perceived norms around smear testing: “(1) Cervical smear is now a very routine medical test; (2) 
All women should have regular cervical smears”. Cronbach’s α for the 4 items was 0.79. 
Possible scores ranged from 4 to 20, higher scores indicating more positive attitude to cervical 
smear testing. Vaccination information trust was measured by two items addressing trust in 
formal (from doctors/health agencies) and informal (from friends/colleagues/neighbors) 
information, respectively, adapted from local studies on influenza vaccination information trust 
[21, 26], responding to 5-point agreement scales ranging from 1 “Strongly disagree” to 5 
“Strongly agree”. Cervical screening attendance was measured by asking “Have you ever had 
cervical smear examination?” with responses of “Yes, with no symptoms/discomfort at the time”, 
“Yes, had test because of symptoms/discomfort”, and “Never”. For those who have ever attended 
cervical screening, the frequency of attendance was also asked. HPV vaccination uptake was 
measured by asking whether the participant had received HPV vaccination, possible responses 
being “Yes” or “No”. HPV vaccination intention was measured by asking participants who had 
not vaccinated against HPV about the likelihood of receiving the vaccination within next 6 
months using 7-point Likert scales (from 1 “definitely not” to 7 “certain”). The questionnaire 
was reviewed by a panel of public health experts to check the instrument’s content and face 
validity and pilot-tested among 27 Hong Kong Chinese adult women to assess the 
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comprehensibility, the flow of the questionnaire in general, and to locate any problems that 
called for necessary fine-tuning before the official fieldwork started. 
Data Analysis 
Data were analyzed using SPSS version 20.0 and p<0.05 was considered statistically significant. 
Descriptive statistics were used to outline the participants’ demographic characteristics and to 
summarize the measured variables. Given most of the independent variables were categorical 
variables, logistic regression analysis was suitable for the current study. For analysis purpose, 
cervical screening attendance was re-coded as a dichotomous variable with responses of 
“Asymptomatic screening” and “Screened with symptoms or never screened”. Vaccination 
intention was dichotomized by grouping Even/Likely/Very likely/Certain to “likely to be 
vaccinated” (indicating a positive intention) and Unlikely/Very unlikely/Never to “Unlikely to be 
vaccinated”. All demographic variables and attitudes to cervical smear test were entered into 
multivariate logistic regression to identify factors associated with asymptomatic screening 
attendance behavior. Furthermore, all demographic variables and variables on information trust 
and vaccination recommendations were entered into logistic regression to calculate adjusted odds 
ratios (AOR) of factors associated with adult women’s HPV vaccination uptake and intention to 
uptake, respectively. All measured variables had less than 1% missing data except demographic 
information where family income was missing in around 10% of cases. For multivariate logistic 
regression, cases with missing data were removed list-wise. 
Results 
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Participants’ characteristics 
From February to November 2014 a total of 1996 respondents successfully completed the 
baseline interviews with effective response rate of 60% (1996/3337). Only female respondents 
(N=1482) were included in the current analysis. Table 1 details their characteristics. Majority 
participants were married (94%) and had secondary or above educational attainment (92%). For 
respondents born overseas the duration of Hong Kong residency ranged from 2 to 56 years 
(mean=19, SD=10.4). About 55% of participants had family incomes of HK$20,000 or above per 
month, comparable to the median domestic income (HK$20,500) of Hong Kong [27].  
Information sources and information trust 
Although all participants had heard of HPV vaccine (commonly referred as “cervical cancer 
vaccine” in Chinese), only half of the participants (50.4%, 747/1482) reported having ever heard 
the term “HPV” before the interview. Nevertheless, overall only 4.6% (68/1482) correctly 
identified HPV infection as the cause/risk factor of cervical cancer (Figure 1). More than half 
(53.7%, 796/1482) of all participants attributed cervical cancer to sexual activity, of which 
37.7% (300/796) particularly cited promiscuity. Only 0.8% (12/1482) of the participants linked 
cervical cancer to smoking. The most common sources of HPV vaccine-related information were 
TV (72.5%, 1074/1482), leaflet/posters from hospitals/MCHCs/private clinics (52.5%, 
778/1482), and newspapers (21.4%, 317/1482). More than half (61.2%, 907/1482) of all 
participants reported that they felt the amount of information about HPV vaccines they have 
obtained was less than they desired. Overall, 91.6% (1357/1482) of the participants reported that 
their doctors had never spoken to them about HPV vaccination, only 3.6% (53/1482) ever 
received positive vaccination recommendation from doctors and another 1.4% (21/1482) 
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participants were discouraged by doctors regarding HPV vaccination. A higher proportion of 
participants (10.9%, 161/1482) had received encouragement from family or friends for HPV 
vaccination uptake, although more than half (59.6%, 883/1482) of the participants reported that 
their family/friends had never discussed HPV vaccination with them. 
Most (89.2%, 1322/1482) participants reported they would trust formal HPV vaccination 
information (from doctors) and fewer (51.3%, 761/1482) tended to trust informal information 
from friends/colleagues/neighbors regarding HPV vaccines. Notably participants born outside of 
Hong Kong (χ2=18.86, p<0.001), having lower educational attainment (χ2=23.49, p<0.001) and 
lower family incomes (χ2=20.79, p<0.001) were more likely to report trusting informal 
information, whereas no significant associations were found between participants’ demographics 
and trust in formal information from doctors. 
Cervical screening attendance 
Participants’ attitudes to cervical smear testing generally appeared quite positive (mean=17/20, 
SD=2.19). Participants who were younger (p=0.023), born overseas (p<0.001), and who had 
secondary education level (p=0.028) expressed more positive attitudes to cervical screening than 
did their counterparts. 
Overall, 17.8% (264/1482) of the participants reported that they had either never been screened 
or only undergone symptomatic screening, while 80.8% (1197/1482) undertook asymptomatic 
screening. Multivariate logistic regression analysis showed that participants with higher family 
income, and holding more positive attitudes to cervical smear testing were more likely to attend 
for asymptomatic cervical screening (Table 2).  
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Most participants (73.0%, 1082/1482) reported they attended for regular screening. Among 1033 
participant women who indicated their screening intervals, 40.4% attended for screening at least 
annually, 70.0% at least bi-annually and 97.5% at least tri-annually. The maximum screening 
interval reported was 6 years (0.4%). Most (82.4%) participants had never had an abnormal Pap 
smear results. 
HPV vaccination uptake and vaccination intention  
Overall only 3.0% (45/1482) of the participating women reported having received HPV 
vaccination, comprising 5.1% (6/117) of 30-39 year-olds, 4.1% (36/887) 40-49 year-olds, and 
0.4% (2/459) of 50-59 year-olds.  
Participants’ vaccination uptake was positively associated with younger age (below 50 years) 
and encouragement from family/friends, but negatively associated with middle-level household 
income and lack of concrete vaccination advice from doctors (Table 2).  
Among 1,437 women who had not received HPV vaccination, overall 12.7% indicated a positive 
intention to be vaccinated in the coming 6 months, comprising 23.9% (26/109) of 30-39 year-
olds, 15.0% (125/836) of 40-49 year-olds, and 6.7% (30/448) of 50-59 year-olds. Women aged 
below 50, born out of Hong Kong, who had middle-level family income, had been encouraged 
by family/friends, trusted formal and informal HPV vaccination information, and had never been 
screened or only screened following symptoms were more likely to receive HPV vaccination 
(Table 2). Notably most (89.9%, 1333/1482) participants recognized that regular cervical 
screening remains necessary after HPV vaccination, and this perception seemed not to influence 
their actual and intended HPV vaccination uptake (p>0.05).   
Discussion 
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To illustrate the importance of updating this kind of survey on knowledge and attitudes from 
time to time as knowledge and attitudes can change quite quickly, this study found, in contrast to 
the earlier finding that 90% of Hong Kong Chinese women had never heard of the term HPV and 
had difficulties understanding and accepting the linkage between cervical cancer and the sexually 
transmitted HPV infection [28], now more than half (54%) of the participating women were well 
informed of the link between sexual activity and cervical cancer and 50% were aware of the term 
HPV. This is possibly due to cervical cancer prevention-oriented health education and HPV 
vaccine promotion. In particular, given that most participating women reported that TV, 
leaflet/posters, and newspapers were the most common information sources of HPV vaccines, 
and that vaccine advertising is now also prominent on buses and mass transit railway station 
platforms, HPV vaccination promotion through mass media is most likely to account for the 
observed increase in knowledge. However, some women interviewed continue to believe 
promiscuity leads to cervical cancer despite the high population prevalence of HPV infection, 
suggesting that those women remain unaware of how common HPV infection is or are possibly 
reducing their anxiety through defensive optimistic bias.  
Besides HPV infection, smoking (including passive smoking) is another confirmed important 
contributor to cervical cancer [29-31]. However, very few participants (0.8%) recognized 
smoking to be a contributing factor in cervical cancer, suggesting Chinese women have 
inadequate knowledge about the wider impacts of smoking. This is not uncommon. Lay people 
generally have a limited understanding of the extensive nature and severity of illnesses caused by 
cigarette smoking [4, 32]. Female smokers seem to neglect their increased risk of cervical cancer 
and the increased value of regular cervical screening [33]. Future cancer prevention education 
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and smoking control programmes should emphasize the wider impacts of smoking on women’s 
health. 
In contrast to previous studies conducted shortly after HPV vaccination was introduced which 
reported high vaccination intention (88%) among Chinese adult women [16], however this study 
found that only 3.0% of the 1,482 participating 30-59 year-old women reported having been 
vaccinated, and even among the younger age group (aged 30-39) only 5.1% had been vaccinated 
against HPV. This finding is consistent with local seasonal influenza vaccination studies 
showing significant vaccination intention-uptake gaps both before and after the vaccine was 
introduced [26]. 
In Hong Kong HPV vaccination is primarily offered through private sector doctors, so these 
practitioners are in a privileged position to recommend and prescribe HPV vaccination. However, 
only 8.3% of the participating women reported that their doctors ever talked to them about HPV 
vaccination. Many Hong Kong private doctors’ vaccination advising behaviour may be affected 
by equivocal local government recommendations [34]. Given the absence of government-
organized vaccination programmes or of any clear advice on vaccination, it is unsurprising that 
this translates into the lack of concrete vaccination advice from healthcare professionals that was 
commonly reported [23, 24].  
Whereas previous studies findings suggested that people more trusting of formal information are 
more likely to adopt active health-protective behaviours [21, 22], the present study found that 
trusting what the doctors said about HPV vaccination is associated with women’s vaccination 
intention but not actual uptake, supporting prior local qualitative study findings that in contrast to 
trust in medical authority regarding routine vaccines, once direct payment was involved 
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regarding optional vaccines (including HPV vaccines), trust is undermined by suspicion of 
pecuniary gain, and doubt regarding the motivation behind clinician’s recommendations on 
optional vaccines, particularly from private doctors [24].  
Compared to the general female population data that nearly one-third of eligible women in Hong 
Kong had never had cervical smear tests [3], a high cervical screening attendance rate was 
observed among our sample, with 81% of participants having ever attended asymptomatic 
screening and 73% attending screening regularly, probably because this sample included higher 
proportion of middle-to-old-aged married women than general female population. Over-
screening was common with 40% of the regular attendees seeking annual screening and 70% 
being screened at least biannually, consistent with earlier study findings that women who are 
being screened are screened more frequently than necessary [6]. Conversely, women who are 
never screened may continue to have higher risk since the cervical screening program in Hong 
Kong does not proactively recruit eligible but never-screened women, suggesting the design of 
the current screening system is inadequate and wastes resources.  
Financial cost is likely to be a major barrier for cervical cancer prevention, particularly among 
women of lower social-economics status, given women with lower family income were less 
likely to seek cervical smear testing unless symptomatic. The lack of choice of female 
practitioners discourages many Hong Kong Chinese women from utilizing screening services 
provided by the affordable government sector, while the high financial cost in the private sector 
blocks utilization there [4]. Cost is also a barrier to HPV vaccination uptake [13, 24, 35]. A 
recently published survey revealed potential social disparities in HPV vaccination with Hong 
Kong adolescent girls who are socio-economically advantaged (locally born, mothers educated to 
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tertiary level or above) being more likely to be vaccinated [36]. Therefore, making cervical 
screening and HPV vaccination accessible and affordable would potentially reduce women’s 
health disparities in Hong Kong. 
This study has several limitations suggesting that the results should be interpreted with some 
degree of caution. The current analysis is based on cross-sectional data. Therefore, causal 
relationships between the variables could not be drawn from the present data. Second, the present 
study did not measure socio-psychological determinants of cervical cancer preventive behaviours 
among adult women per se, such as perceived personal risk of cervical cancer, attitudes to HPV 
vaccination, and perceived self-efficacy, although those variables were assessed in the main 
study that considered HPV vaccination for daughters. Therefore, we could not draw a conclusion 
from current analysis regarding whether cultural beliefs about HPV being a sexually-transmitted 
infection affect women’s HPV vaccination uptake. However, our study found that more than half 
(54%) of the participant women were aware of the link between sexual activity and cervical 
cancer, multivariate logistic regression showed that there were no association between awareness 
of HPV and HPV vaccination uptake or intention to uptake, although previous qualitative studies 
found that some Chinese women considered HPV vaccination to be unnecessary or dispensable 
and believed that adopting a ‘proper’ lifestyle characterized by monogamy and condom use 
could help reduce the risk of cervical cancer [4]. The third limitation results from subjects 
recruitment criteria, which may limit the generalizability of study findings to the wider general 
adult female population. Nevertheless, this study adds important insights for understanding 
Chinese adult women’s cervical cancer prevention practices and associated factors in this 
population. 
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Table 1. Characteristics of participants, Hong Kong 2014 (N=1482) 
Characteristics n % a 
Age group (years)   
 30-39 117 7.9 
 40-49 894 60.3 
 50-59 464 31.3 
Marital status    
 Married 1390 93.8 
 Single/Divorced/Widowed/Separated 88 5.9 
Education level  
 Primary or below 112 7.6 
 Secondary 1087 73.3 
 Tertiary or above 278 18.8 
Employment   
 Employed 664 44.8 
 Currently unemployed 809 54.6 
Personal income (HK$/month)   
 No income 632 42.6 
 1- <10,000 327 22.1 
 10,000 - <20,000 239 16.1 
 20,000 - <40,000 135 9.1 
 ≥40,000  92 6.2 
Family income (HK$/month)  
 <10,000 119 8.0 
 10,000 - <20,000 381 25.7 
 20,000 - <40,000 442 29.8 
 ≥40,000  369 24.9 
Birth place   
 Hong Kong 867 58.5 
 Out of Hong Kong 606 40.9 
Had family history of cancer 468 31.6 
 a
 Unaccounted percentage is missing data. 
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Table 2. Determinants of cervical cancer screening and HPV vaccination among Chinese 
adult women in Hong Kong 2014 (N=1482) using multivariable logistic regression. 
Characteristics 
 
Asymptomatic 
screening 
attendance 
 
Vaccination 
uptake 
 
Vaccination 
intention a 
 AOR (95% CI)  AOR (95% CI)  AOR (95% CI) 
Age (years)    
 
 
 30-39 1.11 (0.60-2.01)  16.33* (1.36-
196.23) 
 
3.32*** (1.70-
6.49) 
 40-49 0.93 (0.66-1.30)  3.74* (1.58-
119.79) 
 
2 36*** (1.47-
3.81) 
 50-59  1.00  .00  1 00 
Place of birth      
 Hong Kong 1.35 (0.97-1.88)  0.73 (0.29-1.86)  0.67* (0.45-0.99) 
 Out of Hong Kong 1.00  1.00  1.00 
Marital status       
 Married 0.89 (0.47-1.67)  0.71 (0.12-4.10)  0.96 (0.39-2.36) 
 
Single/Widowed/Divorced/Sep
arated 
1.00  1.00  1.00 
Education level      
 Primary or below 1.00  1.00  1.00 
 Secondary 0.93 (0.54-1.59)  0.98 (0.17-5.56)  1.29 (0.65-2.55) 
 Tertiary or above 0.995 (0.48-2.08)  0.33 (0.04-2.77)  1.28 (0.51-3.18) 
Employment      
 Employed 0.75 (0.44-1.29)  0.70 (0.14-3.48)  1.06 (0.60-1.90) 
 Currently unemployed 1.00  1.00  1.00 
Personal income (HK$/month)      
 No income 1.00  1.00  1.00 
 1- <10,000 1.52 (0.89-2.59)  0.52 (0.11-2.42)  1.29 (0.72-2.33) 
 10,000 - <20,000 1.23 (0.65-2.33)  1.37 (0.20-9.35)  1.10 (0.54-2.25) 
 20,000 - <40,000 1.53 (0.67-3.50)  1.53 (0.21-11.04)  0.61 (0.22-1.73) 
 ≥40,000  2.03 (0.71-5.78)  0.45 (0.03-7.69)  1.03 (0.32-3.31) 
Household income (HK$/month)    
 
 
 <10,000 1.00  1.00  1.00 
 10,000 - <20,000 1.83* (1.09-3.06)  0.09** (0.02-0.51)  3.51** (1.45-8.51) 
 20,000 - <40,000 2.75*** (1.59-
4.78) 
 0.22* (0.05-0.95)  2.73* (1.09-6.84) 
 ≥40,000 3 01** (1.54-
5.89) 
 0.49 (0.10-2.49)  2.00 (0.69-5.83) 
Heard of HPV      
 Yes 1.03 (0.75-1.40)  1.98(0.80-4.94)  0.98 (0.67-1.41) 
 No 1.00  1.00  1.00 
Had family history of cancer      
 Yes 0.96 (0.69-1.34)  0.71 (0.27-1.90)  0.79 (0.53-1.19) 
 No 1.00  1.00  1.00 
Attitude to cervical smear test 1.21*** (1.13-  ---------------------  --------------------- 
Trust in formal information       
 Yes ---------------------  3.09 (0.31-31.13)  4.17** (1.47-
11.83) 
 No ---------------------  1.00  .00 
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Trust in informal information 
about HPV Vaccination 
     
 Yes ---------------------  1.83 (0.74-4.55)  1.52* (1.05-2.10) 
 No ---------------------  1.00  1.00 
Opinions from doctors      
 Discourage to vaccinate ---------------------  1.00  1.00 
 No concrete recommendation ---------------------  0.09* (0.01-0.90)  1.49 (0.18-12.33) 
 Encourage to vaccinate ---------------------  2.99 (0.28-31.54)  8.82 (0.92-84.48) 
Opinions from family/friends      
 Discourage to vaccinate ---------------------  1.00  1.00 
 No recommendation ---------------------  4.18 (0.38-46.23)  1.71 (0.74-3.94) 
 Encourage to vaccinate ---------------------  15.73* (1.34-
184.87) 
 3.05* (1.21-7.71) 
Cervical screening attendance      
 
Screened with symptoms or 
never screened 
---------------------  1.05 (0.35-3.15)  1.59* (1.03-2.45) 
 
Asymptomatic screening 
symptoms 
---------------------  1.00  1.00 
Perceived necessity of screening 
after vaccination 
     
 Need ---------------------  0.86 (0.20-3.67)  0.67 (0.38-1.18) 
 No need/Not sure ---------------------  1.00  1.00 
AOR, Adjusted Odds Ratio; CI, Confidence Interval; a Among 1437 participants who had not 
been vaccinated against HPV by the interview, 1399 participants indicated their intention of 
getting HPV vaccination in the next 6 months. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 1. Proportions of adult Hong Kong Chinese women attributing different causes/risk 
factors for cervical cancer 2014 (N=1482). 
 
 
 
 
 
 
 
